Try our Advanced Search for more refined results
Cannabis
Cannabis Law360 provides breaking news and analysis of emerging and evolving legal issues surrounding cannabis. Coverage ranges from regulatory and policy concerns facing the industry to the business of lawyers who counsel cannabis companies. Among the practice areas covered are intellectual property, mergers & acquisitions and employment.
Sign up for a 7-day FREE trial today!
Latest News in Cannabis
-
January 07, 2026
FDA Pushes Back On Vape Cos.' 5th Circ. Appeal
The U.S. Food and Drug Administration is urging the Fifth Circuit to reject a group of appeals from e-cigarette manufacturers seeking to overturn the marketing denial of their flavored vapes, saying the agency did not abuse its discretion in rejecting the companies' products.
-
January 06, 2026
Vape Interests Look To 5th Circ. To Halt Miss. E-Cig Law
A coalition of vaping interests is asking the Fifth Circuit to revive its lawsuit seeking to end a Mississippi law that blocks the sale of synthetic nicotine products, the same parties that are also moving forward with similar efforts at the Sixth Circuit.
-
January 06, 2026
Cannabis Staffing Co. Claims CEO Hid Competitor In Merger
A Colorado-based cannabis industry staffing company has claimed in state court that the CEO of a Missouri cannabis staffing company it merged with this year hid a separate staffing agency during the merger and continued to operate the hidden business in violation of the purchase agreement.
-
January 06, 2026
Indiana Lawmaker Files Marijuana Decriminalization Bill
An Indiana state lawmaker has introduced legislation to decriminalize personal possession of small amounts of marijuana.
-
January 06, 2026
Top Personal Injury, Medical Malpractice Cases Of 2025
A headline-grabbing $329 million wrongful death verdict against Tesla and a landmark $2.5 billion deal between DuPont and New Jersey over PFAS "forever chemicals" are among Law360's top personal injury and medical malpractice cases from 2025.
Areas of Coverage
- AGENCIES
- U.S. Food & Drug Administration
- Federal Trade Commission
- Drug Enforcement Agency
- U.S. Department of the Treasury
- California Bureau of Cannabis Control
- Department of Health & Human Services
- Financial Crimes Enforcement Network
- U.S. Securities and Exchange Commission
- U.S. Commodity Futures Trading Commission
- U.S. Department of Justice
- State and international regulators
- POLICY & REGULATION
- SAFE Banking Act
- STATES Act
- Marijuana Opportunity Reinvestment and Expungement, or MORE, Act
- Section 280E of the Internal Revenue Code
- Rohrabacher–Farr amendment
- Bank Secrecy Act
- Federal and state legislation
- ENFORCEMENT
- FDA and FTC actions over cannabis’s purported health claims
- IRS actions against cannabis companies
- Antitrust investigations
- Financial regulatory actions
- Federal criminal matters
- State enforcement actions
- LITIGATION
- Civil RICO actions brought against cannabis concerns
- Employment disputes
- Securities class actions
- Intellectual property matters
- Consumer class actions
- Bankruptcy
- Tax disputes
- Challenges to federal or state regulations
- TRANSACTIONS
- M&A activity involving cannabis companies
- Commercial real estate transactions
- PROFILES
- Personnel moves
- Profiles of law firm cannabis practices
- Federal and state policymakers and lawmakers
- General counsel interviews
READERSHIP
- Cannabis lawyers at large to medium-sized law firms and boutiques
- In-house counsel, compliance officers and executives at cannabis companies
- Counsel and executives at venture capital and investment firms
- Policymakers at federal and state agencies
- Federal and state lawmakers
- Judges and court staff across the U.S.
- Professors, students, and library staff at every accredited law school in the U.S.